COMMUNIQUÉS West-GlobeNewswire
-
MoonLake Immunotherapeutics Announces Proposed Public Offering
22/06/2026 -
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month
22/06/2026 -
Pioneering screening test offers potential to find more aggressive prostate cancers
22/06/2026 -
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
22/06/2026 -
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
22/06/2026 -
NADP and AADOM announce partnership
22/06/2026 -
Genista Launches Refreshed Brand and Website, Positioning Itself as the Operating System for Product Safety
22/06/2026 -
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
22/06/2026 -
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2026
22/06/2026 -
Ozari Health Releases 2026 Online GLP-1 Provider Checklist
22/06/2026 -
IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2026
22/06/2026 -
Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit
22/06/2026 -
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
22/06/2026 -
Novel Key Terms For Managing CIDP Published in Neurology® Journal
22/06/2026 -
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
22/06/2026 -
Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
22/06/2026 -
Route 92 Medical Announces First Commercial Cases in Canada
22/06/2026 -
Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis
22/06/2026 -
GuideAI Health Receives FDA 510(k) Clearance for VascularAssist Occlusion Triage
22/06/2026
Pages